Antileukemic Effect of Palladium Nanoparticles Mediated by White Tea (Camellia sinensis) Extract In Vitro and in WEHI-3B-Induced Leukemia In Vivo

Othman, Hemn, Rahman, Heshu, Mohan, Syam, Aziz, Sadat, Marif, Hardi, Ford, Dianne, Abdulsamad, Nozlena, Amin, Kawa and Abdullah, Rasedee (2020) Antileukemic Effect of Palladium Nanoparticles Mediated by White Tea (Camellia sinensis) Extract In Vitro and in WEHI-3B-Induced Leukemia In Vivo. Evidence-Based Complementary and Alternative Medicine, 2020. p. 8764096. ISSN 1741-427X

[img]
Preview
Text
8764096.pdf - Published Version
Available under License Creative Commons Attribution 4.0.

Download (10MB) | Preview
Official URL: https://doi.org/10.1155/2020/8764096

Abstract

This study investigated the in vivo antileukemic activity of palladium nanoparticles (Pd@W.tea-NPs) mediated by white tea extract in a murine model. The cell viability effect of Pd@W.tea-NPs, "blank"Pd nanoparticles, and white tea extract alone was determined in murine leukemia WEHI-3B cells and normal mouse fibroblasts (3T3 cells). Apoptotic and cell cycle arrest effects of Pd@W.tea-NPs in WEHI-3B cells were evaluated. The effects of Pd@W.tea-NPs administered orally to leukemic mice at 50 and 100 mg/kg daily over 28 days were evaluated. Pd@W.tea-NPs reduced the viability of WHEI-3B cells with IC50 7.55 μg/ml at 72 h. Blank Pd nanoparticles and white tea extract alone had smaller effects on WHEI-3B viability and on normal fibroblasts. Pd@W.tea-NPs increased the proportion of Annexin V-positive WHEI-3B cells and induced G2/M cell cycle arrest. Leukemic cells in the spleen were reduced by Pd@W.tea-NPs with an increase in Bax/Bcl-2 and cytochrome-C protein and mRNA levels indicating the activation of the mitochondrial apoptotic pathway. These effects replicated the effects of ATRA and were not observed using blank Pd nanoparticles. Pd@W.tea-NPs afford therapeutic efficacy against leukemia likely to pivot on activation of the mitochondrial pathway of apoptotic signaling and hence appear attractive potential candidates for development as a novel anticancer agent.

Item Type: Article
Subjects: A900 Others in Medicine and Dentistry
B300 Complementary Medicine
B900 Others in Subjects allied to Medicine
Department: Faculties > Health and Life Sciences > Applied Sciences
Depositing User: Rachel Branson
Date Deposited: 17 Feb 2021 09:40
Last Modified: 05 Mar 2021 16:30
URI: http://nrl.northumbria.ac.uk/id/eprint/45452

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics